Infinium Pharmachem
Infinium Pharmachem Performance
Day Range
- Low 264.1
- High 264.2
52 Week Range
- Low 70.75
- High 315.7
- Open Price264.1
- Previous Close278
- Volume34000
Start SIP in Infinium Pharmachem
Start SIPInfinium Pharmachem Investment Rating
-
Master Rating:
-
Infinium Pharmachem Ltd has an operating revenue of Rs. 322.72 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 11% is healthy, ROE of 42% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 51% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 2 indicates it belongs to a strong industry group of Comml Svcs-Healthcare and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Mar 2023 | Mar 2022 |
---|---|---|
Total Revenue Annual Cr | 103 | 75 |
Operating Expenses Annual Cr | 86 | 65 |
Operating Profit Annual in Cr | 15 | 9 |
Depreciation Cr | 1 | 1 |
Interest Annual Cr | 3 | 2 |
Tax Annual Cr | 3 | 2 |
Net Profit Annual Cr | 9 | 6 |
Infinium Pharmachem Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹274.03
- 50 Day
- ₹239.58
- 100 Day
- ₹190.4
- 200 Day
- ₹
- 20 Day
- ₹272.93
- 50 Day
- ₹234.43
- 100 Day
- ₹186.51
- 200 Day
- ₹
Infinium Pharmachem Resistance and Support
Resistance | |
---|---|
First Resistance | ₹264.17 |
Second Resistance | ₹264.24 |
Third Resistance | ₹264.27 |
RSI | 49.39 |
MFI | 52.65 |
MACD Single Line | 18.31 |
MACD | 14.96 |
Support | |
---|---|
First Resistance | ₹264.07 |
Second Resistance | ₹264.04 |
Third Resistance | ₹263.97 |
Infinium Pharmachem Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 34,000 | 3,200,080 | 94.12 |
Week | 14,800 | 1,359,972 | 91.89 |
1 Month | 11,286 | 1,014,247 | 89.87 |
6 Month | 28,661 | 2,387,772 | 83.31 |
Infinium Pharmachem Result Highlights
Infinium Pharmachem Synopsis
NSE-Comml Svcs-Healthcare
Infinium Pharmachem belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 101.31 Cr. and Equity Capital is Rs. 5.08 Cr. for the Year ended 31/03/2023. Infinium Pharmachem Ltd. is a Public Limited Listed company incorporated on 21/11/2003 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24231GJ2003PLC043218 and registration number is 043218.Market Cap | 368 |
Sales | 101 |
Shares in Float | 1.39 |
No of funds | |
Yield |
Book Value | 12.37 |
U/D Vol ratio | 1.5 |
LTDebt / Equity | |
Alpha | 1.35 |
Beta | -1.33 |
Infinium Pharmachem
Owner Name |
---|
Infinium Pharmachem Management
Name | Designation |
---|---|
Mr. Sanjaykumar Viththalbhai Patel | Chairman & Managing Director |
Mr. Pravin Bhadabhai Madhani | Executive Director |
Mr. Mitesh Lavjibhai Chikhaliya | Executive Director |
Mr. Keyur Jagdishchandra Shah | Independent Director |
Mr. Tarun Ratilal Dobariya | Independent Director |
Mr. Vaishakhi Ambrishbhai Shukla | Independent Director |
Infinium Pharmachem Forecast
Price Estimates
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Infinium Pharmachem FAQs
What is Share Price of Infinium Pharmachem ?
Infinium Pharmachem share price is ₹264 As on 01 October, 2023 | 20:25
What is the Market Cap of Infinium Pharmachem ?
The Market Cap of Infinium Pharmachem is ₹367.5 Cr As on 01 October, 2023 | 20:25
What is the P/E ratio of Infinium Pharmachem ?
The P/E ratio of Infinium Pharmachem is As on 01 October, 2023 | 20:25
What is the PB ratio of Infinium Pharmachem ?
The PB ratio of Infinium Pharmachem is 15.5 As on 01 October, 2023 | 20:25